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Abstract
Objectives To compare the efficacy of two quantitative
methods for discrimination between benign and malignant
focal liver lesions (FLLs): apparent diffusion coefficient
(ADC) values and T2 relaxation times.
Methods Seventy-three patients with 215 confirmed FLLs
(115 benign, 100 malignant) underwent 1.5-T MRI with
respiratory-triggered single-shot SE DWI (b050, 400, 800)
and dual-echo T2TSE (TR03,000 ms; TE1084 ms; TE20
228 ms). ADC values and T2 relaxation times of FLLs were
calculated. Sensitivity, specificity and accuracy of both tech-
niques in diagnosing malignancy were assessed.
Results The mean ADC value of malignant tumours (1.07×
10−3 mm2/s) was significantly lower (P<0.05) than that of
benign lesions (1.86×10−3 mm2/s ); however, with the use of
the optimal cut-off value of 1.25×10−3 mm2/s, 20 false pos-
itive (FP) and 20 false negative (FN) diagnoses of malignancy
were noted, generating 79 % sensitivity, 82.6 % specificity
and 80.9 % accuracy. The mean T2 relaxation time of malig-
nant tumours (64.4 ms) was significantly lower (P<0.05) than
that of benign lesions (476.1 ms). At the threshold of 107 ms
22 FP and 1 FN diagnoses were noted; the sensitivity was
99 %, specificity 80.9 % and accuracy 89.3 %.
Conclusions Quantitative analysis of T2 relaxation times
yielded significantly higher sensitivity and accuracy in di-
agnosing malignant liver tumour than ADC values.
Key Points
• Diffusion-weighted magnetic resonance imaging is in-
creasingly used for liver lesions.
• But ADC values demonstrated only moderate accuracy
for differentiation of liver lesions.
• T2 relaxation times yielded higher accuracy in diagnosing
malignant liver tumours.
• Both ADC and T2 values overlapped between focal nodular
hyperplasia and malignant lesions.
• Nevertheless T2 liver mapping could be valuable for
evaluating focal liver lesions.
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During the past decade magnetic resonance imaging
(MRI) has emerged as the leading modality for the
detection, characterisation and preoperative assessment
of focal liver lesions (FLLs) [1–7]. Advances in MRI
technology have allowed the implementation of several
MR sequences, such as 3D T1-weighted fast spoiled
gradient echo (GE) and diffusion-weighted imaging
echo-planar imaging (DW EPI), for the routine application
in abdominal imaging.
Researchers recently investigated the efficacy of DW
imaging based on quantitative analysis of apparent dif-
fusion coefficient (ADC) values of liver lesions to dif-
ferentiate between benign and malignant lesions [8–21].
The results of most of them were promising, as they
demonstrated statistically significant differences between
higher mean ADC values of benign lesions and lower
mean ADC values of malignant tumours [7, 9–13, 16,
18]. Since the diffusion coefficient is related to lesion
cellularity and the size of extracellular space, some
highly cellular benign lesions such as focal nodular
hyperplasia (FNH) or hepatocellular adenoma (HCA)
showed lower ADC values in the range of those of
malignant lesions [14]. Moreover, in a number of ab-
scesses diffusion was restricted because of cellular de-
bris and exudates [22]. Conversely, some malignant
lesions, mostly metastases, demonstrated high ADC values
[12, 14].
Before the implementation of DW MR liver imaging,
another quantitative method based on calculation of T2
relaxation times of FLLs was used for the character-
isation of liver tumours by several investigators [23–33].
Analysis of T2 relaxation times of hepatic lesions en-
abled the discrimination of nonsolid and solid liver
lesions. Whereas the first group contains almost exclu-
sively benign lesions (e.g. cysts, haemangiomas, ab-
scesses), the second encompasses the majority of
malignant masses (e.g. metastases, hepatocellular carci-
noma, cholangiocarcinoma), but also includes some be-
nign tumours, such as FNH and HCA, which often
exhibit T2 values similar to those of malignant neoplasms
[32].
To our knowledge, there are no published studies
comparing ADC values obtained with DW MR imaging
and T2 relaxation times for the differentiation of liver
lesions. Thus, the purpose of this study was to compare
the accuracy of two quantitative techniques for the
characterisation of focal liver lesions: evaluation of
ADC values based on the SE EPI sequence and assess-




FromMay 2008 to January 2010, 125 patients underwent MR
imaging of the liver at our institution. The MRI studies were
conducted according to our routine liver protocol, which in-
cluded respiratory-triggered diffusion-weighted single-shot
echo-planar imaging (DW-SS-EPI) and dual-echo turbo spin-
echo sequence. Fifty-two patients were excluded from our
analysis due to (1) lack of sufficient data to confirm the nature
of the lesions, (2) no focal liver lesion detected on MR imag-
ing or (3) small size of FLLs detected on MR imaging (max-
imum diameter less than 5 mm). Thus, the study group
comprised 73 patients (34 male, 39 female) with a mean age
of 54.2 years (age range 18–84 years). Six patients had liver
cirrhosis. In one patient with hepatocellular carcinoma there
was no evidence of hepatic cirrhosis. One patient underwent
right hemihepatectomy for treatment of liver metastases before
MR imaging; another underwent hepatic segmentectomy due
to HCC beforeMR. Three patients had previously been treated
with chemotherapy, although not within the year before MR.
Hepatic lesions were solitary in 19 patients and multiple
in 54 patients. In 24 patients only malignant liver lesions
were detected, in 7 patients both malignant and benign
lesions were diagnosed and the remaining 42 patients had
only benign lesions, although 8 of them had more than one
type of benign lesion. In patients with multiple lesions, a
maximum of 5 lesions per patient were selected for analysis
(including lesions which were largest, most conspicuous and
easiest to localise).
A total of 215 hepatic lesions were evaluated (115 be-
nign, 100 malignant) comprising 47 haemangiomas, 42
cysts, 13 FNHs, 12 abscesses, 1 biliary cystadenoma, 65
metastases, 19 hepatocellular carcinomas (HCCs), 13 hae-
mangioendotheliomas, 2 peripheral cholangiocarcinomas
(CCAs) and 1 biliary cystadenocarcinoma. The primary
sites of metastatic lesions included colorectal carcinoma
(n020), neuroendocrine carcinoma (n020), pancreatic ade-
nocarcinoma (n016), gallbladder carcinoma (n05), lung
cancer (n03) and sarcoma (n01).
In 36 of 73 patients (49 %) the reference standard for the
diagnosis was histopathologic proof obtained intra-
operatively in 12 patients (10 patients with malignant tumours
and 2 patients with benign lesions: 1 abscess and 1 biliary
cystadenoma) and from biopsy in 24 patients (21 patients with
malignant masses and 3 patients with benign lesions: 1 hae-
mangioma, 1 FNH, 1 abscess). In the remaining 37 patients no
histological proof was obtained and the final diagnosis was
based on results of previous imaging studies and the follow-up
with a minimum of 6 months’ observation period (US, CT,
MRI), laboratory tests and clinical data.
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MR imaging
Magnetic resonance imaging was performed on a 1.5-T
system (Magnetom Avanto, Siemens Medical Solutions,
Erlangen, Germany), using a phased-array multicoil system
(12 elements).
Analysed breath-hold dual-echo T2-weighted TSE
images and DW-SS-EPI were part of our routine liver im-
aging protocol, which consisted of the respiratory-triggered
T2-weighted TSE sequence with fat saturation, the breath-
hold in- and out-of-phase spoiled gradient dual-echo se-
quence, and a dynamic contrast-enhanced 3D gradient-
echo volumetric interpolated breath-hold examination
(VIBE) sequence, performed during arterial, portal venous,
equilibrium and delayed phases and in hepato-biliary phase
(after injection of gadobenate dimeglumine).
Diffusion-weighted images were acquired using the SE
single-shot echo-planar sequence in the axial plane with
respiratory triggering. Integrated parallel imaging technique
(iPAT) with generalised autocalibrating partially parallel
acquisition (GRAPPA) and an acceleration factor of 2
was applied. The other parameters were as follows:
repetition time (TR) 1,700 ms, TE 90 ms, flip angle
90°, EPI factor 120, slice thickness 6 mm, 120×192
matrix, 2 acquisitions, field of view 344 mm, bandwidth
1,736 Hz/pixel, spectral fat suppression. Diffusion gra-
dients were applied in three orthogonal directions sepa-
rately with three increasing b values of 50, 400 and
800 s/mm2.
The breath-hold dual-echo TSE sequence was performed
in the axial plane with repetition time (TR) 1,800 ms, first
effective TE (TEeff) 84 ms, second TEeff 228 ms, flip angle
150°, turbo factor 29, slice thickness 6 mm, 207×256 ma-
trix, 1 acquisition, acceleration factor of 2, field of view
340 mm, bandwidth 260 Hz/pixel.
Image analysis
ADC measurements were performed on a commercial work-
station (Leonardo, Siemens Medical Solution, Erlangen,
Germany) by drawing regions of interest (ROIs) on DWI
images, which provided the best delineation of analysed
liver lesions. The ROI included the largest possible part of
the lesion, avoiding partial volume effects, areas of necrosis,
blood vessels and artefacts. Then the ROI was copied and
pasted from the DWI image to the corresponding ADC map
and the measurement on ADC map was recorded. The ADC
was measured twice for each lesion and the two measure-
ments were averaged.
ADC values were calculated by mono-exponential regres-
sion with following formula: S0S0exp(−bADC), where S is
the signal intensity after application of the diffusion gradient
and S0 is the signal intensity at b00 s/mm
2. Three b values
(50, 400, 800 s/mm2) were applied for ADC calculation.
On dual-echo T2-weighted TSE images signal intensities
(SI) of all analysed lesions were measured, separately for
each echo time (TE1084 ms, TE20228 ms). Two measure-
ments of SI of each lesion were performed and the mean
values were used for calculation of the T2 relaxation time. If
the lesion consisted of solid and liquid parts, measurements
(ROIs) were confined to its solid component, just as in ADC
measurements.
Assuming that TR is much greater than T1, the standard
equation for SE signal intensity may be simplified to SI0K
exp−(TE/T2), where K is a machine-dependent constant [3].
Therefore, the natural logarithm of signal intensity on SE
image is linearly related to TE with a slope of −1/T2 [8].
T2 relaxation times of liver lesions were calculated
according to the following formula:
T2ðmsÞ ¼ ðTE2 TE1Þ=ðlnSI1 lnSI2Þ;
where TE1 is the first echo time (84 ms), TE2 is the second
echo time (228 ms), lnSI1 and lnSI2 are the natural loga-
rithms of the measured SI for TE1 and TE2, respectively.
Statistical analysis
The statistical analysis was performed using Statistica soft-
ware (version 10.0).
The Mann–Whitney U test was applied to assess statisti-
cally significant differences between the mean ADC values
and between mean T2 relaxation times of benign and ma-
lignant focal liver lesions. This test was also used to assess
statistically significant differences between lesions’ sizes in
selected groups.
The χ2 test was used to compare sensitivities, specificities,
accuracies, positive predictive values (PPV) and negative
predictive values (NPV) of both quantitative techniques
implemented for differentiation of FLLs. A P value of less
than 0.05 was considered significant.
A receiver operating characteristic (ROC) curve analysis
was implemented to define ADC and T2 cut-off values for the
optimal differentiation of benign and malignant liver lesions.
The accuracy of each MR technique (ADC versus T2
relaxation times) was determined by calculating the area
under the ROC curve (AUC). The differences between
ROC curves were tested for significance.
Results
Mean ADC values and mean T2 relaxation times of ana-
lysed benign and malignant hepatic lesions are shown in
Table 1.
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The mean ADC value of malignant FLLs was 1.07×
10−3 mm2/s, ranging from 0.74×10−3 to 2.2×10−3 mm2/s,
whereas the mean ADC value of benign FLLs was 1.86×
10−3 mm2/s, ranging from 0.67×10−3 to 3.22×10−3 mm2/s
(Fig. 1). The difference between mean ADC values of
malignant and benign FLLs was statistically significant
(P<0.001). The calculated area under the ROC curve for
diagnosing malignant lesion was 0.874 (95 % CI 0.823,
0.962), with a sensitivity of 79 % and a specificity of
82.6 %, using a cut-off ADC value of 1.25×10−3 mm2/s.
The mean T2 relaxation time of malignant FLLs was
lower than that of benign FLLs: 64.4 ms (range 45.83–
117.49 ms) vs. 476.06 ms (range 49.87–2,630.82 ms) and
the difference was statistically significant (P<0.001; Fig. 2).
The area under the ROC curve for diagnosing malignancy
was 0.932 (95 % CI 0.891, 0.962), with sensitivity of 99 %
and specificity of 80.9 %, using a threshold of 107 ms. The
area under the ROC curve for T2 times was significantly
larger (P<0.001) than the area under the ROC curve for
ADC values (Fig. 3).
The sensitivities, specificities, accuracies, PPV and NPV
for both quantitative techniques (ADC values and T2 relax-
ation times) at optimal threshold values are summarised in
Table 2.
Analysis of T2 relaxation times yielded significantly
higher sensitivity (P<0.001), accuracy (P00.015) and
Fig. 1 Box plots of ADC
values of 115 benign and 100
malignant liver lesions show
that despite ADC values
of benign lesions being
significantly higher than those
of malignant tumours
(P<0.001), ADC values of both
lesion types considerably
overlapped. Median is shown
as a small box inside each bar
Table 1 Mean ADC values and
mean T2 relaxation times of
benign and malignant
liver lesions and
corresponding 95 % CI
Type of lesion (number) Mean ADC (×10−3 mm2/s) 95 % CI Mean T2 (ms) 95 % CI
Benign lesions (n0115)
Haemangioma (n047) 1.55 (1.465–1.641) 124.3 (116.74–131.92)
Cyst (n042) 2.45 (1.282–2.621) 1,007 (821.18–1,192.78)
FNH (n013) 1.18 (0.994–1.36) 62.8 (54.8–70.77)
Abscess (n012) 1.5 (1.147–1.856) 406.8 (133.86–679.82)
Cystadenoma (n01) 3.3 459
Malignant lesions (n0100)
Metastasis (n065) 1.05 (0.934–1.169) 65.3 (61.68–68.92)
HCC (n019) 0.94 (0.876–1.0) 59.1 (55.42–62.77)
Haemangioendothelioma (n013) 1.3 (1.171–1.437) 64.9 (56.64–73.16)
Cholangiocarcinoma (n02) 0.89 55.7
Cystadenocarcinoma (n01) 2.2 117.5
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NPV (P<0.001) for diagnosing a malignant lesion than
the use of ADC values, whereas the differences in
specificity (P00.64) and PPV (P00.59) were not statis-
tically significant.
Fig. 2 Box plots of T2
relaxation times of 115 benign
and 100 malignant liver lesions
show that T2 times of benign
lesions were significantly
higher than those of malignant
tumours (p<0.001), although
there is some overlap. Median
is shown as a small box inside
(benign lesions) or outside
(malignant lesions) bars.
Nineteen benign lesions
(18 cysts and 1 abscess) with
T2 relaxation times above
1,000 ms were excluded from
the plot for the sake of
better visualisation
Fig. 3 ROC curves for ADC
values (line) and T2 relaxation
times (dots) show that T2 times
were more effective than
ADC values in classification of
focal liver lesions. The area
under the ROC curve for T2
times (0.932; 95 % CI 0.891,
0.962) was significantly
larger than the area under the
ROC curve for ADC values
(0.874; 95 % CI 0.823, 0.962)
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With the use of ADC values 20 false positive diagnoses
of malignant lesions (9 FNHs, 6 haemangiomas, 3 abscess-
es, 2 cysts) and 21 false negative cases (13 metastases, 7
haemangioendotheliomas, 1 cystadenocarcinoma) were not-
ed (Figs. 4, 5 and 6). Therefore, a total of 41 FLLs were
misclassified using ADC quantifications. The primary sites
of 13 misclassified metastatic lesions included neuroendo-
crine tumour (n05; Fig. 4), pancreatic adenocarcinoma
(n04), colorectal carcinoma (n03) and sarcoma (n01).
The implementation of T2 calculations resulted in 22 false
positive diagnoses of malignant FLL (13 FNHs, 8 haemangio-
mas, 1 cyst) and only one false negative case (biliary cystade-
nocarcinoma). No metastatic lesion or HCC was misclassified
with the use of this technique. In total, quantitative analysis of
T2 relaxation times led to 23 hepatic lesion misclassifications,
including all examined FNHs. The mean size of 8 haemangio-
mas falsely diagnosed as malignant (12.3 mm) was signifi-
cantly smaller (P<0.05) than the mean size of all studied
haemangiomas (19.8 mm). Four out of 8 misclassified hae-
mangiomas were smaller or equal to 8 mm, whereas the
remaining lesions ranged from 13 to 21 mm (Fig. 5).
Discussion
Several groups of researchers have published promising
results regarding the implementation of DW MR imaging
for the detection [2, 3, 7, 15, 34–40] and characterisation of
focal liver lesions [7, 10–13, 16, 17]. Some of these pub-
lications have suggested that DW MR images and ADC
maps may be useful in the differentiation of benign and
malignant lesions [7, 10–13, 16, 18].
Given the limitations of visual assessment, quantitative
analysis based on ADC values of FLLs has been proposed
for the discrimination of benign from malignant lesions
[7–16, 18–21]. However, investigators using ADC quantifi-
cation have reported varying sensitivities (range 74–100 %)
and different specificities (range 77–100 %) in diagnosing
of malignant lesions [9, 10, 12–14] . Moreover, significant
differences in ADC cut-offs ranging from 1.47×10−3 to
Table 2 Sensitivities, specificities, PPV, NPV and accuracies for di-
agnosing malignancy using optimal cut-off ADC values and T2 relax-
ation times
ADC values T2 times
Cut-off values 1.25 (×10−3 mm2/s) 107 (ms)
Sensitivity (%) 79 99
Specificity (%) 82.6 80.9
Accuracy (%) 80.9 89.3
PPV (%) 79.8 81.8
NPV (%) 81.9 98.9
Fig. 4 MR images obtained in a 51-year-old womanwith liver metastases
from neuroendocrine cancer. a b050 s/mm2 DW SS EPI image. b b0
800 s/mm2 DW SS EPI image. c Corresponding ADC map. Double echo
TSE images: d TR/TE: 3,000/84 ms, e TR/TE 3,000/228 ms. The first
metastatic lesion (arrow) displaying increased signal intensity on b050
and b0800 images and on ADC map had an ADC value of 1.43×
10−3 mm2/s (false negative diagnosis of malignancy). The second lesion
(arrowhead) shows increased signal intensity on b050 and b0800 images
and decreased signal on ADC map consistent with restricted diffusion
(ADC value01.24×10−3 mm2/s). Both lesions had T2 relaxation times in
the range of those of a malignant lesion (58.9 ms and 98.6 ms)
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1.63×10−3 mm2/s have been proposed for the optimal dif-
ferentiation of benign and malignant lesions [9, 10, 12–14].
In the current study, the sensitivity and specificity for the
detection of malignant lesions were in the range of those of
previous studies (79 % and 82.6 %, respectively), although
the ADC cut-off was significantly lower (1.25×10−3 mm2/
s). There are several possible reasons explaining this differ-
ence, including the use of different hardware, absence of
standardization of image acquisition (choice of different b
values), various methods for ADC calculation and different
patient populations.
The choice of b values (number, range, the first b value)
and the method for ADC calculation (mono-exponential
versus bi-exponential model) have important implications
for the calculated ADC values. For instance, application of a
two-point mono-exponential regression with low b values
(including b00 s/mm2) results in the overestimation of ADC
(higher obtained ADC values) owing to the incorporated
effect of perfusion [6, 41, 42]. The ADC calculated with
higher b values (including the first b value of at least 50 s/
mm2) is lower and probably more reliable [6, 42]. The DW
technique used by us comprised multiple and higher b
values than in the majority of prior studies and omitted the
lowest b value of 0, leading to some decrease of the perfu-
sion effect. Such a choice of parameters resulted in lower
mean ADC values being obtained for liver lesions and a
lower ADC cut-off for differentiation of FLLs.
The patient population also has important implications
for the performance of ADC quantification in FLL charac-
terisation. The best results were obtained by investigators
who studied patients with no or a small number of solid
benign tumours (FNH, HCA) and abscesses, which often
have ADC values in the range of those of malignant lesions
[12, 13]. Gourtsoyianni et al. studied a group of patients
with 15 solid malignant tumours (13 metastases, 2 HCCs)
and 22 non-solid benign lesions (15 cysts, 7 haemangiomas)
obtaining the highest possible sensitivity and specificity
(100 %) for diagnosing malignancy [13]. No solid benign
lesions, such as FNH or HCA, were included in their study
population, decreasing the probability of false positive di-
agnosis of malignant lesions. In the group of 204 liver
lesions studied by Bruegel et al. only 4 FNHs were noted,
representing less than 3.6 % of 111 analysed benign lesions
[12]. These authors reported high sensitivity and specificity
for diagnosing malignant tumour (90 % and 86 %, respec-
tively) [12]. Less promising but probably more realistic
results were obtained by Parikh et al. (74 % sensitivity,
77 % specificity), who analysed 211 liver lesions. In this
group, the number and percentage of solid benign lesions (5
adenomas and 4 FNHs, 12 %) were higher and could
Fig. 5 MR images obtained in a
53-year-old woman with hepatic
haemangiomas. a b050 s/mm2
DW SS EPI image. b b0800
s/mm2 DW SS EPI image. c
Corresponding ADC map. Dou-
ble echo TSE images: d TR/TE
3,000/84 ms, e TR/TE 3,000/
228 ms. Both haemangiomas
show increased signal intensity
on b050 and b0800 images and
on ADC map; however, in the
case of the haemangioma located
in the left liver lobe (arrow), the
decrease in signal intensity on
b0800 image and hyperintensity
on ADC map are more pro-
nounced (ADC value01.75×
10−3 mm2/s—true negative case)
than in the second haemangioma
(arrowhead) located in the right
liver lobe (ADC value of 1.23×
10−3 mm2/s—false positive di-
agnosis of malignancy). T2 time
of the haemangioma in left liver
lobe (arrow) is in the range of
those of malignancies (80.9 ms),
whereas T2 time of second hae-
mangioma (125.5 ms) is in the
range of those of benign lesions
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influence the diagnostic performance of ADC values [14].
In our study group solid benign lesions (13 FNHs) consti-
tuted 11.3 % of all benign lesions, a percentage similar to
that in Parikh et al.’s study. ADC values of 9 of 13 FNHs
were in the range of those of malignant tumours (false
positive diagnoses), leading, along with 3 abscesses and 6
haemangiomas, to a decrease in specificity (82.6 %).
In the current study we attempted to compare the perfor-
mance of DW MRI with T2-weighted TSE imaging for the
discrimination between benign and malignant lesions. Pre-
viously such comparisons were performed, but only by
applying qualitative, visual assessment of FLLs on T2-
weighted images [14, 15]. As reported by Fenlon et al.,
who compared quantitative and qualitative analyses of FLLs
on T2-weighted SE images, quantitative evaluation of T2
relaxation times allowed more accurate and confident dif-
ferentiation between benign and malignant lesions [31]. To
the best of our knowledge, this study is the first attempt
to compare two available quantitative methods of FLL
characterisation: calculation of ADC values and T2 re-
laxation times.
In the past T2 quantifications were successfully applied
by several groups using different techniques of image ac-
quisition, including conventional SE, moderately T2-
weighted TSE, heavily T2-weighted TSE and T2 EPI
sequences with a varied number of echoes utilized for T2
calculations [23–33]. Goldberg et al., who derived T2 cal-
culations from echo-planar sequences with four different
echo times, obtained 100 % accuracy in the differentiation
between solid and non-solid lesions [26]. McFarland et al.,
using a dual-echo heavily T2-weighted SE sequence,
reported 100 % sensitivity and 92 % specificity for the
discrimination of haemangiomas and malignant tumours
[27]. Cieszanowski et al. implemented a dual-echo moder-
ately T2-weighted sequence, achieving 98 % sensitivity and
96 % specificity, for diagnosing solid lesions [32].
In our comparative study of two quantitative techniques,
the sensitivity for the diagnosis of malignant lesions was
Fig. 6 MR images obtained in an 83-year-old man with hepatic
abscesses located in segment VIII. a b050 s/mm2 DW SS EPI image.
b b0800 s/mm2 DW SS EPI image. c Corresponding ADC map. Double
echo TSE images: d TR/TE 3,000/84ms, e TR/TE 3,000/228ms. OnDW
images (b050, b0800) the cavity of the first abscess (arrow) displays
high signal intensity, which markedly decreases on ADC map, represent-
ing restricted diffusion (ADC value of 0.94×10−3 mm2/s—false positive
diagnosis of malignancy). The cavity of the second abscess (arrowhead)
shows increased signal on b050 DW image, mixed on b0800 DW image
and mostly increased on ADC map (ADC value of 1.27×10−3 mm2/s in
the range of those of benign lesions). On axial T2-weighted images
obtained with TE of 84 ms (d) and 228 ms (e) increased signal in noted
in both cavities corresponding to relative long T2 times of 293 ms and
238 ms, typical for benign lesions. Abscesses demonstrate typical periph-
eral capsular enhancement on portal phase 3D GRE axial image (f)
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significantly higher with the use of T2 values (99 %) than
with ADC values (79 %). Implementation of T2 times led to
only a single false negative diagnosis of malignancy (cys-
tadenocarcinoma), whereas ADC quantification resulted in
21 such cases (13 metastases, 7 haemangioendotheliomas, 1
cystadenocarcinoma). Slightly more numerous false positive
diagnoses of malignant lesions were noted with analysis of
T2 relaxation times than with ADC values (22 vs. 20)
leading to better specificity of ADC quantification (82.6 %
vs. 80.9 %). Moreover, 13 FNHs (all in our study popula-
tion), which accounted for most of the 23 misclassified
hepatic lesions by T2 quantifications, had typical appear-
ance on contrast-enhanced images. Therefore, the combined
evaluation of all obtained MR images would lead to the
correct diagnosis in these cases.
Beside FNHs, the majority of remaining false positive
cases of malignancy for T2 calculations were 8 haemangio-
mas (Fig. 5). Their mean size of 12.3 mm was considerably
smaller than the mean size of all studied haemangiomas
(19.8 mm). Thus, it is possible that the decrease of T2
relaxation times in some of these cases could result from
the volume averaging effect.
Several limitations of this study should be mentioned.
Firstly, we applied only three b values (50, 400, 800 s/mm2);
therefore, calculated ACD values are approximate. The in-
clusion of more b values would probably lead to more
accurate ADC calculation, however at the expense of pro-
longed examination time. Secondly, mono-exponential re-
gression using three b values (50, 400, 800 s/mm2) was
implemented for ADC calculations. The ADC value
depends not only on diffusion but also incorporates the
effect of perfusion and signal attenuation is bi-exponential
with DW imaging. We cannot exclude that application of a
bi-exponential model using more b values for ADC calcu-
lation would result in obtaining more reliable ADC values.
Thirdly, we implemented only two echoes in the T2-
weighted TSE sequence. Inclusion of more echoes would
probably lead to more accurate estimation of T2 relaxation
times of FLLs, but at the expense of extended imaging time.
Fourthly, the composition of our study population did not
fully represent the typical spectrum of liver lesions, includ-
ing 13 haemangioendotheliomas and lacking adenomas.
Finally, histopathological proof was not available in 37 of
73 patients (51 %), although it was obtained in all patients
with malignant lesions.
The results of our study confirm that the DWI technique
with ADC quantification has potential in the differentiation of
FLLs. However, in this first published comparison of two
quantitative techniques (ADC quantification vs. T2 times
calculation) for characterisation of FLLs, T2 values yielded
significantly higher sensitivity for diagnosing malignant
lesions than ADC values. It is at variance with the results of
previous publications comparing DWMRI with T2-weighted
TSE imaging, although in these studies only qualitative as-
sessment of T2-weighted images was employed [14, 15].
Compared with assessment of ADC values on ADC
maps, generated automatically on a commercial worksta-
tion, analysis of T2 times of FLLs was not that simple and
required separate, manual drawing of ROIs on images ac-
quired with different TEs and then transferring all data to a
PC to obtain T2 values using a commercial calculation sheet
(Excel, Microsoft). In our opinion, inclusion of multiple-
echo T2-weighted TSE sequences in MR protocols dedicat-
ed for liver imaging, along with automatically generated T2
maps on commercial MR consoles (similarly to ADC maps
or T2 mapping used for assessment of articular cartilage),
should be considered by MR vendors. We presume that it
would provide important quantitative data, helpful in the
differentiation of FLLs.
Despite the usefulness of T2 and ADC quantification for
the differentiation of FLLs, some pitfalls of these techniques
must be kept in mind. There is substantial overlap between
highly cellular, solid benign lesions, such as FNH, HCA and
malignant tumours (HCC, metastases) on both DW and T2-
weighted TSE images. Moreover, some abscesses, due to
cellular debris and exudates, may also display restricted
diffusion. Therefore, DW and T2-weighted images should
be used as complementary methods for the characterisation
of FLLs, in conjunction with clinical context and pre- and
post-contrast T1-weighted scans, including dynamic and
hepatobiliary phase images. In our material the most impor-
tant advantage of T2 quantification over ADC values was
the more confident characterisation of metastatic lesions,
abscesses and haemangioendotheliomas.
In conclusion, comparison of the two quantitative methods
used for the characterisation of FLLs demonstrated signifi-
cantly higher sensitivity and accuracy of T2 relaxation times
than ADC values (99 % and 89.3 % versus 79 % and 80.9 %,
respectively) for diagnosing hepatic malignancy. Inclusion of
multiple-echo T2-weighted TSE sequences in MRI liver pro-
tocols together with T2 mapping of the liver on MR consoles
may be an additional valuable tool facilitating the discrimina-
tion of malignant and benign hepatic lesions.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution License which permits any use, distribution,
and reproduction in any medium, provided the original author(s) and
the source are credited.
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